Torres, Ana
Younis, Brima Musa
Alamin, Mohammed
Tesema, Samuel
Bernardo, Lorena
Solana, Jose Carlos
Moreno, Javier
Mustafa, Alaa-aldeen
Alves, Fabiana
Musa, Ahmed Mudawi
Carrillo, Eugenia
Funding for this research was provided by:
Instituto de Salud Carlos III (ISCIII-AES project (PI18CIII/00029))
Centro de Investigación Biotecnológica en Red de Enfermedades Infecciosas (CB21/13/00018)
Drugs for Neglected Diseases initiative (MVP322/19)
Article History
Received: 16 February 2024
Accepted: 23 June 2024
First Online: 15 July 2024
Declarations
:
: All patients provided written informed consent to be included; assent was obtained from minors aged > 12 to < 18 years in addition to guardian consent. The protocol for this study was designed in accordance with the ethical principles outlined in the Declaration of Helsinki and the International Committee for Harmonization Guidelines for Good Clinical Practice, and approved by the ethics committee of Faculty of Medicine, University of Khartoum and the Sudanese National Medicines and Poisons Board.
: We the undersigned qualify as authors to this manuscript and warrant that: (1) this submission has not been previously published, nor is it before another journal for consideration; (2) nobody who qualifies for authorship has been excluded; (3) this article is original, does not infringe on any copyright or other proprietary right of any third party, and; (4) the article is not under consideration by another journal and has not been previously published. We agree to the manuscript’s submission to the journal Journal of Epidemiology and Global Health and, if accepted, to its publication in this journal.
: The authors declare no competing interests.